台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼3.0
  • 漲幅
    -2.90%
  • 成交量
    1,644
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-元富-板橋 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/0803/1803/2804/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0202/1202/249095100105110115120125May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元富-板橋 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/2812102.211101.03100.50111,7520.63%
2025/03/272103.7500.00103.5021,7280.12%
2025/03/260105.3300.00104.5001,7230.00%
2025/03/2520105.000105.50104.50201,7191.16%
2025/03/241105.500106.50105.5011,7140.06%
2025/03/2100.001107.00106.50-11,714-0.06%
2025/03/201105.511106.50106.0001,7130.00%
2025/03/191105.002107.00104.50-11,718-0.06%
2025/03/180106.0000.00106.5001,7130.00%
2025/03/171105.511107.00105.0001,7140.00%
2025/03/140104.671105.00105.00-11,713-0.06%
2025/03/132103.0000.00103.5021,7070.12%
2025/03/121107.5000.00107.0011,6950.06%
2025/03/113105.674107.13107.00-11,697-0.06%
2025/03/101107.0000.00107.0011,6860.06%
2025/03/074108.5000.00107.5041,6650.24%
2025/03/063110.830113.50111.0031,6470.18%
2025/03/050115.001114.50115.50-11,645-0.06%
2025/03/040112.253114.50114.50-31,634-0.18%
2025/03/031113.001114.00112.5001,6200.00%
2025/02/275110.8000.00109.0051,5680.32%
2025/02/266116.754116.25115.5021,5530.13%
2025/02/2500.002116.00113.00-21,443-0.14%
2025/02/240114.001113.50115.00-11,431-0.07%
2025/02/211112.5000.00113.0011,4120.07%
2025/02/200110.5900.00110.0001,3890.00%
2025/02/190109.5900.00110.0001,3960.00%
2025/02/180111.251109.00110.00-11,401-0.07%
2025/02/140111.0700.00111.5001,4080.00%
2025/02/130111.2500.00111.5001,4130.00%
2025/02/122111.992107.50112.0001,4080.00%
2025/02/112112.0000.00109.0021,3920.14%
2025/02/100119.5000.00118.5001,3370.00%
2025/02/0700.0011118.18120.50-111,351-0.81%
2025/02/067119.938118.88119.00-11,329-0.08%
2025/02/052112.001112.50113.0011,1940.08%
2025/02/0400.003101.50103.00-31,201-0.25%
2025/01/20092.70093.3093.6001,2790.00%
2025/01/13497.0000.0096.3041,3700.29%
2025/01/1000.000.296.4097.00-0.21,355-0.01%
2025/01/0700.002102.00101.50-21,275-0.16%
2025/01/03197.30197.5098.3001,2400.00%
2024/12/3000.00291.9091.00-21,224-0.16%
2024/12/2700.001192.7292.00-111,223-0.90%
2024/12/20088.0000.0086.2001,2130.00%
2024/12/17886.5000.0086.7081,2230.65%
2024/12/13388.0000.0088.8031,2090.25%
2024/12/12490.8000.0090.2041,1990.33%
2024/12/1000.00092.3092.1001,1880.00%
2024/12/0900.00192.9092.50-11,184-0.08%
2024/12/0500.00195.2094.60-11,170-0.09%
2024/12/0300.00094.6094.4001,1610.00%
2024/12/02194.70297.5094.40-11,158-0.09%
2024/11/2900.00297.0097.50-21,136-0.18%
2024/11/28294.5500.0092.4021,1100.18%
2024/11/22295.7500.0093.8021,0310.19%
2024/11/20096.7000.0096.5001,0180.00%
2024/11/1800.00296.7096.50-21,010-0.20%
2024/11/0600.000102.50102.5008260.00%
2024/11/0400.004105.00100.00-4758-0.53%
2024/11/014104.133.1106.48105.0017300.13%
2024/10/3000.000.1100.00102.00-0.1617-0.01%
2024/10/291101.000101.00100.5016040.16%
2024/10/286102.333102.33102.0035760.51%
2024/10/2500.002.198.0797.40-2.1513-0.41%
2024/10/2400.0014.599.9798.30-14.5494-2.94%
2024/10/21088.0000.0086.7004180.01%
2024/10/0800.00591.8891.10-5507-0.98%
2024/09/2400.000.188.2090.20-0.1612-0.01%
2024/09/20085.9000.0087.4006440.00%
2024/09/13082.7000.0082.2006440.00%
2024/09/09082.0000.0082.0006660.00%
2024/09/040.182.9400.0082.000.16980.01%
2024/09/02086.8000.0086.6007190.00%
2024/08/30086.9000.0087.6007260.00%
2024/08/200.185.9500.0085.800.17420.01%
2024/08/16084.6000.0084.6007430.00%
2024/08/14083.8000.0083.6007550.00%
2024/08/130.184.3200.0084.400.17720.01%
2024/08/08086.4000.0085.4007990.00%
2024/08/07185.2000.0086.7017940.13%
2024/08/0500.00383.0083.00-3764-0.39%
2024/07/30092.7000.0093.6007360.00%
2024/07/2900.00295.0094.50-2736-0.27%
2024/07/23093.9000.0094.5007200.00%
2024/07/22094.5000.0092.0007180.00%
2024/07/17298.4000.0098.2026580.30%
2024/07/0800.0021100.50100.50-21655-3.20%
2024/07/022197.8400.0097.80216233.37%
2024/07/013101.001100.00101.0026100.33%
2024/06/27197.7000.0095.7015820.17%
2024/06/2600.00396.5397.60-3576-0.52%
2024/06/20094.1000.0094.5006350.00%
2024/06/19193.70194.1093.8006370.00%
2024/06/17295.9500.0095.5026440.31%
2024/06/14195.4000.0095.3016550.15%
2024/06/1100.00295.0095.40-2636-0.31%
2024/06/04091.8000.0090.8006470.01%
2024/05/3100.00091.0090.6007290.00%
2024/05/30191.7900.0090.3017370.14%
2024/05/29092.3000.0091.5007470.00%
2024/05/28092.67092.1092.3007600.00%
2024/05/241.193.19093.6092.8018080.13%
2024/05/2300.00094.6093.6008420.00%
2024/05/2200.00095.5094.1008470.00%
2024/05/2100.00096.9095.1008500.00%
2024/05/20097.70097.8096.9008650.00%
2024/05/1700.00197.3097.90-1872-0.11%
2024/05/14296.70194.3094.3011,0430.10%
2024/05/13092.6300.0092.6001,0380.00%
2024/05/07093.1000.0092.8001,1160.00%
2024/04/2900.00095.0095.3001,4300.00%
2024/04/230.189.80089.7790.2001,4980.00%
2024/04/220.188.97189.4088.00-0.91,512-0.06%
2024/04/192.189.56189.4089.001.11,5230.07%
2024/04/170.193.70193.8092.60-0.91,541-0.06%
2024/04/16091.1000.0091.0001,5570.00%
2024/04/15094.2000.0094.1001,5650.00%
2024/04/09197.60197.9097.6001,7220.00%
2024/04/0800.005100.5099.10-51,770-0.28%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-26天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章